A quinoxaline derivative and ADRENERGIC ALHPA-2 RECEPTOR AGONIST that is used to manage INTRAOCULAR PRESSURE associated with OPEN-ANGLE GLAUCOMA and OCULAR HYPERTENSION.
More specific conditions that are subtypes of Brimonidine Tartrate in the MeSH hierarchy.
Phase 3 trials (1)
Phase 1 trials (1)